Part of redevelopment of a leading cancer center.
Study shows potential of GE-067, GE Healthcare's [18F] labeled analogue of Pittsburgh Compound B (PIB) as a novel PET imaging agent for brain amyloid accumulation related to Alzheimer's disease. Two hour half-life of [18F] labeled ligand offers potential for greater accessibility to clinical centers.
Combining calcium scoring with single photon emission computed tomography (SPECT) can help to identify patients with CAD who are at highest risk.
A first-of-its-kind study finds value providers may be drawn to
New study shows effective dosage for heart exam can be significantly lowered in comparison to conventional CT.
New CEO at Seno Medical Instruments brings over 30 years of medical device experience to the company
Former GE Healthcare Global Diagnostic Imaging CEO joins ControlRad Systems board of directors
Acquires information based on 53 data points to predict rate and length of survival
The Acuros clearance was awarded as part of the market-leading Eclipse™ treatment planning system.
Nuclear medicine approach can be first choice for excluding pulmonary embolism in young women.
Sofinnova Partners appoints venture partner
Advantage in tissue contrast, short exam time for low dose radiation.
"Nothing short of spectacular," says surgeon
The year's biggest event for nuclear medicine and molecular imaging
Our monthly visit to Dr. Blaufox’s Museum of Historical Medical Artifacts
Find out what to expect at the big event and over the next year
